The Impact of Switching to a Second Antifibrotic Therapy on
Outcomes in Patients With IPF in the Empire Registry Treated
With Pirfenidone or Nintedanib

Přeskočit na horní lištu Přeskočit na hlavičku Přeskočit na obsah Přeskočit na patičku

Publikace Přehled o publikaci

Přehled o publikaci

a 2023

The Impact of Switching to a Second Antifibrotic Therapy on Outcomes in Patients With IPF in the Empire Registry Treated With Pirfenidone or Nintedanib

VASAKOVA, M. K.; N. MOGULKOC; M. KRAMER; M. DOUBKOVA; M. PLACKOVA et al.

Základní údaje

Originální název

The Impact of Switching to a Second Antifibrotic Therapy on Outcomes in Patients With IPF in the Empire Registry Treated With Pirfenidone or Nintedanib

Autoři

VASAKOVA, M. K.; N. MOGULKOC; M. KRAMER; M. DOUBKOVA; M. PLACKOVA; V. MUELLER; M. J. STUDNICKA; M. ZURKOVA; L. LACINA; K. LEWANDOWSKA; V. BARTOS; P. OVESNA a Jakub GREGOR

Vydání

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023

Další údaje

Typ výsledku

Konferenční abstrakt

Impakt faktor

Impact factor: 19.300

Označené pro přenos do RIV

ISSN

Změněno: 9. 1. 2026 10:14, Mgr. Jakub Gregor, Ph.D.

VASAKOVA, M. K.; N. MOGULKOC; M. KRAMER; M. DOUBKOVA; M. PLACKOVA; V. MUELLER; M. J. STUDNICKA; M. ZURKOVA; L. LACINA; K. LEWANDOWSKA; V. BARTOS; P. OVESNA a Jakub GREGOR. The Impact of Switching to a Second Antifibrotic Therapy on Outcomes in Patients With IPF in the Empire Registry Treated With Pirfenidone or Nintedanib. In AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2023. ISSN 1073-449X.

@proceedings{2545338,
   author = {Vasakova, M. K. and Mogulkoc, N. and Kramer, M. and Doubkova, M. and Plackova, M. and Mueller, V. and Studnicka, M. J. and Zurkova, M. and Lacina, L. and Lewandowska, K. and Bartos, V. and Ovesna, P. and Gregor, Jakub},
   booktitle = {AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE},
   title = {The Impact of Switching to a Second Antifibrotic Therapy on Outcomes in Patients With IPF in the Empire Registry Treated With Pirfenidone or Nintedanib},
   year = {2023}
}

TY  - CONF
ID  - 2545338
AU  - Vasakova, M. K. - Mogulkoc, N. - Kramer, M. - Doubkova, M. - Plackova, M. - Mueller, V. - Studnicka, M. J. - Zurkova, M. - Lacina, L. - Lewandowska, K. - Bartos, V. - Ovesna, P. - Gregor, Jakub
PY  - 2023
TI  - The Impact of Switching to a Second Antifibrotic Therapy on Outcomes in Patients With IPF in the Empire Registry Treated With Pirfenidone or Nintedanib
ER  -

VASAKOVA, M. K.; N. MOGULKOC; M. KRAMER; M. DOUBKOVA; M. PLACKOVA; V. MUELLER; M. J. STUDNICKA; M. ZURKOVA; L. LACINA; K. LEWANDOWSKA; V. BARTOS; P. OVESNA a Jakub GREGOR. The Impact of Switching to a Second Antifibrotic Therapy on Outcomes in Patients With IPF in the Empire Registry Treated With Pirfenidone or Nintedanib. In \textit{AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE}. 2023. ISSN~1073-449X.